Home
Scholarly Works
PMS46 The Economic Value of Tofacitinib 5 Mg Bid...
Conference

PMS46 The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian Analysis

Authors

Woolcott JC; Blackhouse G; Claxton L; Wallenstein G; Tran T; Goeree R; Taylor M; Moynagh D; Singh A

Volume

18

Pagination

pp. a160-a161

Publisher

Elsevier

Publication Date

May 1, 2015

DOI

10.1016/j.jval.2015.03.931

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015

Contact the Experts team